advertising
-
1
Farr S, Sevelda F, Mader P, et al: Extracorporeal shockwave therapy in calcifying tendinitis of the shoulder. Knee Surg Sports Traumatol Arthrosc 19: 2085, 2011.
-
2
Yan X, Zeng B, Chai Y, et al: Improvement of blood flow, expression of nitric oxide, and vascular endothelial growth factor by low-energy shockwave therapy in random-pattern skin flap model. Ann Plast Surg 61: 646, 2008.
-
3
Kisch T, Wuerfel W, Forstmeier V, et al: Repetitive shock wave therapy improves muscular microcirculation. J Surg Res 201: 440, 2016.
-
4
Bosch G, de Mos M, van Binsbergen R, et al: The effect of focused extracorporeal shock wave therapy on collagen matrix and gene expression in normal tendons and ligaments. Equine Vet J 41: 335, 2009.
-
5
Chen YJ, Wurtz T, Wang CJ, et al: Recruitment of mesenchymal stem cells and expression of TGF-beta 1 and VEGF in the early stage of shock wave-promoted bone regeneration of segmental defect in rats. J Orthop Res 22: 526, 2004.
-
6
Frairia R, Berta L: Biological effects of extracorporeal shock waves on fibroblasts. A review. Muscles Ligaments Tendons J 1: 138, 2012.
-
7
Carulli C, Tonelli F, Innocenti M, et al: Effectiveness of extracorporeal shockwave therapy in three major tendon diseases. J Orthop Traumatol 17: 15, 2016.
-
8
Burger EH, Klein-Nulend J: Mechanotransduction in bone—role of the lacuno-canalicular network. FASEB J 13(suppl): S101, 1999.
-
9
van der Worp H, van den Akker-Scheek I, van Schie H, et al: ESWT for tendinopathy: technology and clinical implications. Knee Surg Sports Traumatol Arthrosc 21: 1451, 2013.
-
10
Ogden JA, Tóth-Kischkat A, Schultheiss R: Principles of shock wave therapy. Clin Orthop Relat Res 387: 8, 2001.
-
11
Wang CJ, Wang FS, Yang KD: Biological effects of extracorporeal shockwave in bone healing: a study in rabbits. Arch Orthop Trauma Surg 128: 879, 2008.
-
12
Liberati A, Altman DG, Tetzlaff J, et al: The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med 151: W–65, 2009.
-
13
Wright JG, Swiontkowski MF, Heckman JD: Introducing levels of evidence to the journal. J Bone Joint Surg Am 85: 1, 2003.
-
14
Wells GA, Shea B, O’Connell D, et al.: Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-analyses, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada, 2012.
-
15
Deng Z, Jin J, Zhao J, et al: Cartilage defect treatments: with or without cells? Mesenchymal stem cells or chondrocytes? Traditional or matrix-assisted? A systematic review and meta-analyses. Stem Cells Int 2016: 9201492, 2016.
-
16
Higgins JP, Thompson SG, Deeks JJ, et al: Measuring inconsistency in meta-analyses. BMJ 327: 557, 2003.
-
17
Haidich AB: Meta-analysis in medical research. Hippokratia 14(suppl 1): 29, 2010.
-
18
Wan X, Wang W, Liu J, et al: Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol 14: 135, 2014.
-
19
Hammer DS, Rupp S, Kreutz A, et al: Extracorporeal shockwave therapy (ESWT) in patients with chronic proximal plantar fasciitis. Foot Ankle Int 23: 309, 2002.
-
20
Kudo P, Dainty K, Clarfield M, et al: Randomized, placebo-controlled, double-blind clinical trial evaluating the treatment of plantar fasciitis with an extracorporeal shockwave therapy (ESWT) device: a North American confirmatory study. J Orthop Res 24: 115, 2006.
-
21
Wang CJ, Wang FS, Yang KD, et al: Long-term results of extracorporeal shockwave treatment for plantar fasciitis. Am J Sports Med 34: 592, 2006.
-
22
Saber N, Diab H, Nassar W, et al: Ultrasound guided local steroid injection versus extracorporeal shockwave therapy in the treatment of plantar fasciitis. Alexandria J Med 48: 35, 2012.
-
23
Saxena A, Fournier M, Gerdesmeyer L, et al: Comparison between extracorporeal shockwave therapy, placebo ESWT and endoscopic plantar fasciotomy for the treatment of chronic plantar heel pain in the athlete. Muscles Ligaments Tendons J 2: 312, 2013.
-
24
Chew KT, Leong D, Lin CY, et al: Comparison of autologous conditioned plasma injection, extracorporeal shockwave therapy, and conventional treatment for plantar fasciitis: a randomized trial. PM R 5: 1035, 2013.
-
25
Gollwitzer H, Saxena A, DiDomenico LA, et al: Clinically relevant effectiveness of focused extracorporeal shock wave therapy in the treatment of chronic plantar fasciitis: a randomized, controlled multicenter study. J Bone Joint Surg Am 97: 701, 2015.
-
26
Chuckpaiwong B, Berkson EM, Theodore GH: Extracorporeal shock wave for chronic proximal plantar fasciitis: 225 patients with results and outcome predictors. J Foot Ankle Surg 48: 148, 2009.
-
27
Gordon R, Wong C, Crawford EJ: Ultrasonographic evaluation of low energy extracorporeal pulse activated therapy (EPAT) for chronic plantar fasciitis. Foot Ankle Int 33: 202, 2012.
-
28
Ilieva EM: Radial shock wave therapy for plantar fasciitis: a one year follow-up study. Folia Med (Plovdiv) 55: 42, 2013.
-
29
Hsu WH, Lai LJ, Chang HY, et al: Effect of shockwave therapy on plantar fasciopathy. A biomechanical prospective. Bone Joint J Br 95: 1088, 2013.
-
30
Maki M, Ikoma K, Imai K, et al: Correlation between the outcome of extracorporeal shockwave therapy and pretreatment MRI findings for chronic plantar fasciitis. Mod Rheumatol 25: 427, 2015.
-
31
Scheuer R, Friedrich M, Hahne J, et al: Approaches to optimize focused extracorporeal shockwave therapy (ESWT) based on an observational study of 363 feet with recalcitrant plantar fasciitis. Int J Surg 27: 1, 2016.
-
32
Gollwitzer H, Diehl P, von Korff A, et al: Extracorporeal shock wave therapy for chronic painful heel syndrome: A prospective, double blind, randomized trial assessing the efficacy of a new electromagnetic shock wave device. J Foot Ankle Surg 46: 348, 2007.
-
33
Moretti B, Garofalo R, Patella V, et al: Extracorporeal shock wave therapy in runners with a symptomatic heel spur. Knee Surg Sports Traumatol Arthrosc 14: 1029, 2006.
-
34
Notarnicola A, Pesce V, Vicenti G, et al: SWAAT study: extracorporeal shock wave therapy and arginine supplementation and other nutraceuticals for insertional Achilles tendinopathy. Adv Ther 29: 799, 2012.
-
35
Notarnicola A, Maccagnano G, Tafuri S, et al: CHELT therapy in the treatment of chronic insertional Achilles tendinopathy. Lasers Med Sci 29: 1217, 2014.
-
36
Fridman R, Cain JD, Weil L Jr, et al: Extracorporeal shockwave therapy for the treatment of Achilles tendinopathies: a prospective study. JAPMA 98: 466, 2008.
-
37
Vulpiani MC, Trischitta D, Trovato P, et al: Extracorporeal shockwave therapy (ESWT) in Achilles tendinopathy. A long-term follow-up observational study. J Sports Med Phys Fitness 49: 171, 2009.
-
38
Saxena A, Ramdath S Jr, O’Halloran P, et al: Extra-corporeal pulsed-activated therapy (“EPAT” sound wave) for Achilles tendinopathy: a prospective study. J Foot Ankle Surg 50: 315, 2011.
-
39
Taylor J, Dunkerley S, Silver D, et al: Extracorporeal shockwave therapy (ESWT) for refractory Achilles tendinopathy: a prospective audit with 2-year follow up. Foot (Edinb) 26: 23, 2016.
-
40
Fridman R, Cain JD, Weil L Jr: Extracorporeal shockwave therapy for interdigital neuroma: a randomized, placebo-controlled, double-blind trial. JAPMA 99: 191, 2009.
-
41
Seok H, Kim SH, Lee SY, et al: Extracorporeal shockwave therapy in patients with Morton's neuroma: a randomized, placebo-controlled trial. JAPMA 106: 93, 2016.
-
42
National Institute for Health Care and Excellence (NICE): NICE Guidance, 2018. Available at: https://www.nice.org.uk/guidance. Accessed.Q5
-
43
Rompe JD, Kirkpatrick CJ, Küllmer K, et al: Dose-related effects of shock waves on rabbit tendo Achillis. J Bone Joint Surg Br 80: 546, 1998.
-
44
Lee SJ, Kang JH, Kim JY, et al: Dose-related effect of extracorporeal shock wave therapy for plantar fasciitis. Ann Rehabil Med 37: 379, 2013.
-
45
Hawker GA, Mian S, Kendzerska T, et al: Measures of adult pain: Visual Analogue Scale (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionaire (MPQ), Short-Form McGill Pain Questionaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF-36 BPS), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP). Arthritis Care Res (Hoboken) 63(suppl 11): S240: 2011.
-
46
Lee JS, Hobden E, Stiell IG, et al: Clinically important change in the visual analog scale after adequate pain control. Acad Emerg Med 10: 1128, 2003.
-
47
Rompe JD, Furia J, Weil L, et al: Shock wave therapy for chronic plantar fasciopathy. Br Med Bull 81-82: 183, 2007.
-
48
Klonschinski T, Ament SJ, Schlereth T, et al: Application of local anesthesia inhibits effects of low-energy extracorporeal shock wave treatment (ESWT) on nociceptors. Pain Med 12: 1532, 2011.
Extracorporeal Shockwave Therapy for Foot and Ankle Disorders: A Systematic Review and Meta-Analysis
Search for other papers by Tengku Nazim B. Tengku Yusof in
Current site
Google Scholar
PubMed
Search for other papers by Dexter Seow in
Current site
Google Scholar
PubMed
Search for other papers by Khushdeep S. Vig in
Current site
Google Scholar
PubMed
Background: Extracorporeal shockwave therapy (ESWT) was first introduced into clinical practice in 1982 and has been a beneficial inclusion to the noninvasive treatment option of numerous orthopaedic pathologies. However, clinical evidence of the use of ESWT for various foot and ankle disorders has been limited with a consensus on its efficacy yet available. Therefore, the purpose of this study is to systematically review the literature, to provide a critical evaluation and meta-analysis for the use of ESWT in foot and ankle disorders.
Methods: The PubMed and Embase databases were systematically reviewed and clinical studies that reported ESWT use for various foot and ankle disorders included.
Results: A total of 24 clinical studies that included 12 randomized controlled trials and 12 case series were identified. Analysis of the evidence has indicated that ESWT can help manage plantar fasciitis, calcaneal spur, Achilles tendinopathy and Morton’s neuroma. Meta-analysis of the change in pre- to post-VAS overall scores for plantar fasciitis significantly favored ESWT compared to placebo/conservative treatment with a MD -3.10 (95% CI, -4.36 to -1.83; I2 = 68%; P < 0.00001).
Conclusions: The current evidence has suggested that ESWT can provide symptomatic benefit to plantar fasciitis treatment, with minimal and unremarkable side effects. Overall, ESWT has been demonstrated to be a safe treatment option with a favorable complication profile. Further well-designed studies of ESWT for the treatment of calcaneal spurs, Achilles tendinopathy and Morton’s neuroma are warranted to more soundly and safely support its current use. Future studies are suggested to investigate the optimization of ESWT treatment protocols.
advertising
